Preferred Consent Models for Secondary Uses of Biospecimens Among Diverse Women

Research with stored biospecimens can provide substantial societal benefits, including greater understanding of cancer etiology and discovery of new cancer therapies, but one critical social and ethical issue is the use of samples for research unplanned at the time of biospecimen collection. Various models for consent (i.e., no consent, notice, opt-out, broad consent, study-specific consent) have been proposed for secondary research use of biospecimens, but empirical data on individuals' preferences for different consent models are limited, particularly from those with limited health literacy and from racial and ethnic minority groups. It is critically important to understand the consent preferences of diverse individuals, as participation of all population subgroups in biobanks is essential to reach translational cancer research goals. Based on a social ecological conceptual framework, the investigators will examine preferences for consent models for secondary research uses of biospecimens among a racially and socioeconomically diverse sample of women 35 years of age and older. The investigators aim to compare experimentally the effect of consent model on intentions to donate biospecimens for future research use among a diverse sample of women. The investigators hypothesize that women will have stronger intentions to donate based on the broad model of consent and the study-specific model of consent compared with the notice model of consent. These findings from groups underrepresented in research will be critical since the participation of these groups in biobanks is essential to generating findings that will achieve translational research goals of eliminating cancer disparities.

Study Overview

Study Type

Interventional

Enrollment (Actual)

302

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • Saint Louis, Missouri, United States, 63110
        • Washington University School of Medicine in St. Louis

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • 35 years old or older
  • Proficient in English
  • Identifies as Non-Hispanic
  • Identifies as African-American or Black
  • Identifies as Caucasian or White
  • Identifies as Female

Exclusion Criteria:

  • Under 35 years old
  • Not proficient in English
  • Identifies as Hispanic
  • Identifies as a race other than African-American or Black; or Caucasian or White
  • Identifies as more than one race
  • Identifies as Male

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Study-specific consent model
• Review plain language brochure describing consent to a biobank based on the study-specific model of consent
• Review plain language brochure describing consent to a biobank based on the study-specific model of consent
• Review plain language brochure describing consent to a biobank based on the broad model of consent
• Review plain language brochure describing consent to a biobank based on the notice model of consent
Other: Broad consent model
• Review plain language brochure describing consent to a biobank based on the broad model of consent
• Review plain language brochure describing consent to a biobank based on the study-specific model of consent
• Review plain language brochure describing consent to a biobank based on the broad model of consent
• Review plain language brochure describing consent to a biobank based on the notice model of consent
Other: Notice consent model
• Review plain language brochure describing consent to a biobank based on the notice model of consent
• Review plain language brochure describing consent to a biobank based on the study-specific model of consent
• Review plain language brochure describing consent to a biobank based on the broad model of consent
• Review plain language brochure describing consent to a biobank based on the notice model of consent

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intent to Donate
Time Frame: Immediate
Intention to donate to a biobank.
Immediate

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Consent Model Preference
Time Frame: Immediate
Preferred type of consent for secondary use of biospecimens.
Immediate

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kimberly A Kaphingst, ScD, The University of Utah
  • Principal Investigator: Bettina Drake, PhD, Washington University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

August 1, 2015

Study Completion (Actual)

August 1, 2015

Study Registration Dates

First Submitted

July 29, 2014

First Submitted That Met QC Criteria

July 30, 2014

First Posted (Estimate)

July 31, 2014

Study Record Updates

Last Update Posted (Actual)

May 14, 2018

Last Update Submitted That Met QC Criteria

May 7, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 201208079
  • 3U54CA153460-03S1 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Biospecimen Donation

Clinical Trials on Study-specific consent model

3
Subscribe